Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations

Given the limitations of current antileishmanial drugs and the utility of oral combination therapy for other infections, developing an oral combination against visceral leishmaniasis should be a high priority. In vitro combination studies with DB766 and antifungal azoles against intracellular Leishm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Joice, April C., Yang, Sihyung, Farahat, Abdelbasset A., Meeds, Heidi, Feng, Mei, Li, Junan, Boykin, David W., Wang, Michael Zhuo, Werbovetz, Karl A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740383/
https://ncbi.nlm.nih.gov/pubmed/29061761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01129-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados